PKfit - A Pharmacokinetic Data Analysis Tool in R

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
SEMINAR ON NONCOMPARTMENTAL PHARMACOKINETICS
Exercise 9 Building and validation of a non linear calibration curve (logistic model) for analytical purposes.
JGuiB - AN ASSISTANT TOOL FOR PHARMACOKINETIC/PHARMACODYNAMIC MODELING WORKING WITH BOOMER Ying-hao Lu 1 *, David W.A. Bourne 2, Yung-jin Lee 1 1 College.
Curve Fitting and Interpolation: Lecture (IV)
Verify or refute the use of Non Linear Mixed Effect Model for Interferon effect on HCV Hila David Shimrit Vashdi Project Advisors: Prof. Avidan Neumann.
Dosage Regimen Design in Patients with Renal Insufficiency Cont’d Pharmacy 732 Winter, 2001.
Development of Empirical Models From Process Data
13-1 Designing Engineering Experiments Every experiment involves a sequence of activities: Conjecture – the original hypothesis that motivates the.
Extravascular administration: monitoring drug in urine.
Pharmacokinetics of Drug Absorption
Nonlinear pharmacokinetics
Two-compartment model
ivivc - A Tool for in vitro- in vivo Correlation Exploration with R
One-compartment open model: Intravenous bolus administration
Week 5- Pharmacokinetics of oral absorption
Laplace transformation
Least-Squares Regression
Christoffer W Tornoe Oct Population PK Model Building 1 Q & A on Session 1 What is naïve pooled analysis? –Definition –One advantage/disadvantage.
Week 4 - Biopharmaceutics and Pharmacokinetics
沈致远. Test error(generalization error): the expected prediction error over an independent test sample Training error: the average loss over the training.
Automating the Lee Model. Major Components Simulator code –Verifying outputs –Verifying model equations –Graphical User interface Auto-tuning the model.
(a.k.a: The statistical bare minimum I should take along from STAT 101)
Gokaraju Rangaraju College of Pharmacy
Bioavailability of Drugs with Nonlinear Pharmacokinetics (PK) Can be Approximated by the Ratio of Doses that Provide Equal Areas under the Concentration-Time.
INTRAVENOUS INFUSION.
On Model Validation Techniques Alex Karagrigoriou University of Cyprus "Quality - Theory and Practice”, ORT Braude College of Engineering, Karmiel, May.
Stats for Engineers Lecture 9. Summary From Last Time Confidence Intervals for the mean t-tables Q Student t-distribution.
Analytical vs. Numerical Minimization Each experimental data point, l, has an error, ε l, associated with it ‣ Difference between the experimentally measured.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 Part 4 Curve Fitting.
Karunya Kandimalla, Ph.D. Assistant Professor, Pharmaceutics
University of Jordan-Faculty of Pharmacy
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Nonlinear Pharmacokinetics Prepared By, Jahanvi H. Patel Roll No:09MPH103 Dept: Pharmaceutical Technology & Biopharmaceutics Guided By: Dhaivat C. Parikh.
1 Develop a Tool for Therapeutic Drug Monitoring in R Using OpenBUGS Speaker: Miao-ting Chen 1, M.S. Mentor: Yung-jin Lee 2 1 Department of Hospital Pharmacy,
Inference for Regression Simple Linear Regression IPS Chapter 10.1 © 2009 W.H. Freeman and Company.
PHARMACOKINETIC MODELS
Solution of a Partial Differential Equations using the Method of Lines
Introduction to PK/PD Modeling for Statisticians Part 1
Population Pharmacokinetic Characteristics of Levosulpiride and Terbinafine in Healthy Male Korean Volunteers Yong-Bok Lee College of Pharmacy and Institute.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
Intravenous bolus administration: monitoring drug in urine
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
AN EXAMPLE OF APPLICATION OF THE POPULATION APPROACH TO TOXICOLOGICAL STUDIES F. Fiorentini 1, M. Simeoni 2, I. Poggesi 1, G. Westerberg 1, M. Rocchetti.
CHAPTER 7 ABSORPTION KINETICS.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Nonlinear Pharmacokinetics
Pharmacokinetics of Vancomycin in Adult Oncology Patients Hadeel Al-Kofide MS.c; Iman Zaghloul PhD; and Lamya Al-Naim PharmD Department of Clinical Pharmacy,
Pharmacokinetics of Drug Absorption Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
Pharmacokinetic Models
Multicompartment Models
1.Andersson, T, et al. Clin Pharmacokinet 2001;40: Hassan-Alin, M, et al. Eur J Clin Pharmacol 2000;56: Population Pharmacokinetic Modelling.
ــــــــــــــ February 17 th, PHT - LECTURE Mathematical Fundamental in Pharmacokinetics Dr. Ahmed Alalaiwe.
Anders Nielsen Technical University of Denmark, DTU-Aqua Mark Maunder Inter-American Tropical Tuna Commission An Introduction.
Statistics 350 Lecture 2. Today Last Day: Section Today: Section 1.6 Homework #1: Chapter 1 Problems (page 33-38): 2, 5, 6, 7, 22, 26, 33, 34,
CMS SAS Users Group Conference Learn more about THE POWER TO KNOW ® October 17, 2011 Medicare Payment Standardization Modeling using SAS Enterprise Miner.
Pharmacokinetics 3rd Lecture
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
Linear model. a type of regression analyses statistical method – both the response variable (Y) and the explanatory variable (X) are continuous variables.
Chapter 7. Classification and Prediction
Chapter 7 COMPARTMENT MODELS
Stock Prediction with ARIMA
Hawler Medical University
Presentation transcript:

PKfit - A Pharmacokinetic Data Analysis Tool in R Speaker: Chun-ying Lee1 Advisor: Yung-jin Lee2 1Pharmacy Department, Changhua Christian Hospital Changhua, Taiwan 2College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan

Motivation Using available packages in R to create the program Selecting menu-driven mode as the user interface Studying the application of genetic algorithm to PK data analysis Comparing with WinNonlin and Boomer WinNonlin http://www.pharsight.com Boomer http://www.boomer.org 2017/4/14

User Interface Menu-driven mode Users need not require to be familiar with programming of R Analyses data step by step 2017/4/14

PK models included Fourteen PK models are currently available (all single-dosed) Intravenous drug administrations with i.v. bolus or i.v. infusion Extravascular drug administrations, linear PK with 1st-order absorption/elimination or with nonlinear (Michaelis-Menten) elimination models 2017/4/14

Model fitting

Packages required odesolve (by R. Woodrow Setzer) lsoda function: solving differential equations rgenoud (by Walter R. Mebane and Jasjeet S. Sekhon ) genoud function: Genetic algorithm stats nls function: Gauss-Newton algorithm (by Douglas M. Bates and Saikat DebRoy) optim function: Nelder-Mead simplex method logLik function: Log-Likelihood (by Jose Pinheiro and Douglas Bates) AIC function: Akaike’s Information Criterion (by Jose Pinheiro and Douglas Bates) stats4 BIC function: Bayesian information criterion 2017/4/14

Coding process 7 2017/4/14

Output information Summary table Time, observed and calculated concentrations Weighted residuals Area under plasma concentration curves (AUC) Area under the first moment curves (AUMC) Final values of PK parameters Model selection criteria Log-Likelihood (LL) Akaike’s Information Criterion (AIC) Schwarz’s Bayesian Criterion (SBC) Diagnostic plots Linear plots Semi-log plots Residual plots 2017/4/14

Validation All the conditions are set the same in these three software Data sets Selected models Initial values for parameters Fitting algorithms and numerical integration tools WinNonlin: Nelder-Mead Simplex method / RKF5 Boomer: Nelder-Mead Simplex  Gauss-Newton / RKF5 Criteria Prediction (absolute) error (PE) Percentage of prediction (absolute) error (%PE) 2017/4/14

Comparison of software WinNonlin Boomer PKfit equal 1/Cp 1/Cp2 Model 1  Model 2 Model 3 Model 4 Model 1: One-Compartment PK Model I.V. Bolus Single-Dose with Linear Elimination Model 2: One-Compartment PK Model I.V. Bolus Single-Dose with Nonlinear Elimination Model 3: One-Compartment PK Model I.V. Infusion Single-Dose with Linear Elimination Model 4: One-Compartment PK Model I.V. Infusion Single-Dose with Nonlinear Elimination : Running O.K. (AE%  5%) 2017/4/14

Comparison of software WinNonlin Boomer PKfit equal 1/Cp 1/Cp2 Model 5  Model 6 X Model 7 Model 8 Model 5: One-Compartment PK Model Extravascular Single-Dose with First-Ordered Absorption and Linear Elimination without Lag Time Model 6: One-Compartment PK Model Extravascular Single-Dose with First-Ordered Absorption and Nonlinear Elimination without Lag Time Model 7: One-Compartment PK Model Extravascular Single-Dose with Zero-Ordered Model 8: One-Compartment PK Model Extravascular Single-Dose with Zero-Ordered : Running O.K. (AE%  5%) X: Not acceptable for final PK parameters (AE% > 5%) 2017/4/14

Comparison of software WinNonlin Boomer PKfit equal 1/Cp 1/Cp2 Model 9  Model 10 Model 11 X Model 9: Two-Compartment PK Model I.V. Bolus Single-Dose with Linear Elimination Model 10: Two-Compartment PK Model I.V. Infusion Single-Dose with Linear Elimination Model 11: Two-Compartment PK Model Extravascular Single-Dose with First-Ordered Absorption and Linear Elimination without Lag Time : Running O.K. (AE%  5%) X: Not acceptable for final PK parameters (AE% > 5%) 2017/4/14

Comparison of software WinNonlin Boomer PKfit equal 1/Cp 1/Cp2 Model 12  Model 13 Model 14 X Model 12: One-Exponential Term Model 13: Two-Exponential Term Model 14: Three-Exponential Term : Running O.K. (AE%  5%) X: Not acceptable for final PK parameters (AE% > 5%) X: Crashed 2017/4/14

Simulation

Packages required stats runif function: random uniform distribution derivates rnorm function: random normal distribution derivates 2017/4/14

Coding process 16 2017/4/14

Output information Time and concentration Linear plot Semi-log plot 2017/4/14

Validation All the simulation results in these three software are very similar with “Error type = No error” with four significant digits WinNonlin Boomer PKfit Time Conc. 0.5 12.39 1 22.29 2 36.15 3 44.14 4 48.08 6 48.64 8 44.33 10 38.37 12 32.27 16 21.82 20 14.34 24 9.314 A one-compartment PK model with extravascular, single-dose with first-ordered absorption without lag time and linear elimination Dose= 500 (mg) ka= 0.32 (1/hr) kel= 0.11 (1/hr) Vd= 5.8 (L) 2017/4/14

Thanks to… Dr. Woodrow Setzer for odesolve Dr. Jasjeet Sekhon for rgenoud Dr. Anthony Rossini for scripting 2017/4/14

Reference R Installation and Administration, Version 2.0.1, 2001. (http://cran.r-project.org/doc/manuals/R-admin.html) R Language Definition, Version 1.9.1, 2004. (http://cran.r-project.org/doc/manuals/R-lang.html) Sekhon, J.S. and Mebane, W.R.Jr., Genetic Optimization Using Derivatives: Theory and Application to Nonlinear Models. Political Analysis, 7:187-210, 1998. Setzer, R.W., The odeslove Package, 2004. The R Project for Statistical Computing. (http://www.r-project.org) Writing R Extensions, Version 1.9.1, 2004. (http://cran.r-project.org/doc/manuals/R-exts.html) 2017/4/14

Thanks for your attention!